NCT01840904

Brief Summary

The purpose of this study is to investigate subjective sleep quality and fatigue during and after Acute uncomplicated diverticulitis assessed by questionnaires and a sleep-diary. The investigators hypothesis is that subjective sleep and fatigue are correlated with the inflammatory activities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

April 13, 2013

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 26, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

February 25, 2014

Status Verified

February 1, 2014

Enrollment Period

7 months

First QC Date

April 13, 2013

Last Update Submit

February 24, 2014

Conditions

Outcome Measures

Primary Outcomes (5)

  • Changes in Sleep quality during acute uncomplicated diverticulitis from baseline score at remission (14th, 21st and 30th day)

    1. subjective sleep quality measured by a Visual Analog Scale (VAS) at given time frame 2. sleep-diary recording sleep quantity of day and night sleep at given time frame

    1st-10th day and 14th, 21st, 30th day following the admission

  • Changes in Sleepiness during acute uncomplicated diverticulitis from baseline score at remission (14th, 21st and 30th day)

    Sleepiness measured by Karolinska Sleepiness Scale at given time frame

    1st-10th day and 14th, 21st, 30th day following the admission

  • Changes in fatigue during acute uncomplicated diverticulitis from baseline score at remission (14th, 21st and 30th day)

    1. General fatigue measured on Visual Analog Scale at given time frame 2. Physical fatigue measured on a 10 points scale at given time frame

    1st-10th day and 14th, 21st, 30th day following the admission

  • Changes in general well-being during acute uncomplicated diverticulitis from baseline score at remission (14th, 21st and 30th day)

    general well being measured on VAS

    1st-10th day and 14th, 21st, 30th day following the admission

  • Changes in pain during acute uncomplicated diverticulitis from baseline score at remission (14th, 21st and 30th day)

    Pain measured on VAS

    1st-10th day and 14th, 21st, 30th day following the admission

Secondary Outcomes (6)

  • accuracy of sleep diary compared to actigraph in measuring sleep data

    1st-10th day and 14th, 21st, 30th day following the admission

  • accuracy of sleep diary compared to Polysomnography (PSG) in measuring sleep data

    1st-2nd day and 30th day following the admission

  • correlation between fatigue and level of cytokines in patient's plasma

    1st and 2nd and 30th day following the admission

  • correlation between pain and level of cytokines in patient's plasma

    1st and 2nd and 30th day following the admission

  • correlation between sleepiness and level of cytokines in patient's plasma

    1st and 2nd and 30th day following the admission

  • +1 more secondary outcomes

Study Arms (1)

acute uncomplicated diverticulitis

CT-verified acute uncomplicated diverticulitis managed by antibiotics

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

16 x Acute uncomplicated diverticulitis (Hansen and stock stage 1) patients aged 18-75 years managed by antibiotic treatment at Herlev Hospital.

You may qualify if:

  • CT-verified diverticulitis patients managed by antibiotic treatment at Herlev Hospital
  • Pain and fever occurred less than 72 hours prior to the admission
  • ASA (American Society of Anesthesiologists) score I to III

You may not qualify if:

  • Surgical intervention needed
  • Complicated diverticulitis
  • Complications in relation to diverticulitis
  • Pain and fever occurred more than 72 hours prior to the admission
  • In anticoagulant treatment and heart rate control treatment
  • Known Autoimmune disease
  • Known medically treated sleep-disorder (insomnia, restless legs etc.) and sleep apnea
  • Shift-work or jetlag
  • Daily use of opioid, psychopharmaca, opioids or anxiolytics (including Hypnotics)
  • Known psychiatry conditions in treatment with psychopharmaca
  • Daily alcohol intake of more than 5 units or drug abuse
  • Missing written consent
  • Diabetes Mellitus
  • Predicted bad compliance
  • Pregnant or breast-feeding
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department D, Herlev Hospital

Herlev, Copenhagen, 2730, Denmark

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

plasma

Study Officials

  • Ismail Gögenur, M.D.

    University of Copenhagen, Herlev Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior resident and D.Sc.

Study Record Dates

First Submitted

April 13, 2013

First Posted

April 26, 2013

Study Start

April 1, 2013

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

February 25, 2014

Record last verified: 2014-02

Locations